跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BENLYSTA belimumab 120 mg powder for injection vial
Approved
STANDARD
BENLYSTA belimumab 120 mg powder for injection vial
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
939d5106c8975918
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
939d5106c8975918
Product Name
BENLYSTA belimumab 120 mg powder for injection vial
Artg Id
173077
Artg Name
BENLYSTA belimumab 120 mg powder for injection vial
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2012-10-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9cc2c577e04fda0e53eeae12e240e0b6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/677c40a736a604c7072e0284c10fac69.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
939d5106c8975918
Type
Standard
Back to TGA Approvals
BENLYSTA belimumab 120 mg powder for injection vial - TGA Drug Approval Details
